Literature DB >> 21069556

Pharmacophore-driven identification of PPARγ agonists from natural sources.

Rasmus K Petersen1, Kathrine B Christensen, Andreana N Assimopoulou, Xavier Fretté, Vassilios P Papageorgiou, Karsten Kristiansen, Irene Kouskoumvekaki.   

Abstract

In a search for more effective and safe anti-diabetic compounds, we developed a pharmacophore model based on partial agonists of PPARγ. The model was used for the virtual screening of the Chinese Natural Product Database (CNPD), a library of plant-derived natural products primarily used in folk medicine. From the resulting hits, we selected methyl oleanonate, a compound found, among others, in Pistacia lentiscus var. Chia oleoresin (Chios mastic gum). The acid of methyl oleanonate, oleanonic acid, was identified as a PPARγ agonist through bioassay-guided chromatographic fractionations of Chios mastic gum fractions, whereas some other sub-fractions exhibited also biological activity towards PPARγ. The results from the present work are two-fold: on the one hand we demonstrate that the pharmacophore model we developed is able to select novel ligand scaffolds that act as PPARγ agonists; while at the same time it manifests that natural products are highly relevant for use in virtual screening-based drug discovery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069556     DOI: 10.1007/s10822-010-9398-5

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  52 in total

1.  Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia.

Authors:  P Magiatis; E Melliou; A L Skaltsounis; I B Chinou; S Mitaku
Journal:  Planta Med       Date:  1999-12       Impact factor: 3.352

2.  Cytotoxic triterpenes from the aerial roots of Ficus microcarpa.

Authors:  Yi-Ming Chiang; Jang-Yang Chang; Ching-Chuan Kuo; Chi-Yen Chang; Yueh-Hsiung Kuo
Journal:  Phytochemistry       Date:  2005-02       Impact factor: 4.072

3.  Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies.

Authors:  Neeraj Mahindroo; Chiung-Chiu Wang; Chun-Chen Liao; Chien-Fu Huang; I-Lin Lu; Tzu-Wen Lien; Yi-Huei Peng; Wei-Jan Huang; Ying-Ting Lin; Ming-Chen Hsu; Chia-Hui Lin; Chia-Hua Tsai; John T-A Hsu; Xin Chen; Ping-Chiang Lyu; Yu-Sheng Chao; Su-Ying Wu; Hsing-Pang Hsieh
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

4.  KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.

Authors:  Kwang Rok Kim; Jeong Hyung Lee; Seung Jun Kim; Sang Dal Rhee; Won Hoon Jung; Sung-Don Yang; Sung Soo Kim; Jin Hee Ahn; Hyae Gyeong Cheon
Journal:  Biochem Pharmacol       Date:  2006-05-12       Impact factor: 5.858

5.  Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori.

Authors:  P Marone; L Bono; E Leone; S Bona; E Carretto; L Perversi
Journal:  J Chemother       Date:  2001-12       Impact factor: 1.714

6.  Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.

Authors:  Michael Schupp; Lucas D Lee; Nikolaj Frost; Sumaira Umbreen; Boris Schmidt; Thomas Unger; Ulrich Kintscher
Journal:  Hypertension       Date:  2005-12-19       Impact factor: 10.190

7.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

8.  Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.

Authors:  Tamara Allen; Fang Zhang; Shonna A Moodie; L Edward Clemens; Aaron Smith; Francine Gregoire; Andrea Bell; George E O Muscat; Thomas A Gustafson
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

9.  Coupling SFE to uterotonic bioassay: an on-line approach to analysing medicinal plants.

Authors:  V Sewram; M W Raynor; D M Raidoo; D A Mulholland
Journal:  J Pharm Biomed Anal       Date:  1998-11       Impact factor: 3.935

10.  Enhancement of preneoplastic lesion yield by Chios Mastic Gum in a rat liver medium-term carcinogenesis bioassay.

Authors:  Kenichiro Doi; Min Wei; Mitsuaki Kitano; Naomi Uematsu; Masayo Inoue; Hideki Wanibuchi
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-15       Impact factor: 4.219

View more
  14 in total

Review 1.  Bioinformatics opportunities for identification and study of medicinal plants.

Authors:  Vivekanand Sharma; Indra Neil Sarkar
Journal:  Brief Bioinform       Date:  2012-05-15       Impact factor: 11.622

Review 2.  The re-emergence of natural products for drug discovery in the genomics era.

Authors:  Alan L Harvey; RuAngelie Edrada-Ebel; Ronald J Quinn
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

3.  Effects of Chios mastic gum and exercise on physical characteristics, blood lipid markers, insulin resistance, and hepatic function in healthy Japanese men.

Authors:  Tomoko Fukazawa; Ilias Smyrnioudis; Masayuki Konishi; Masaki Takahashi; Hyeon Ki Kim; Mio Nishimaki; Mi Xiang; Shizuo Sakamoto
Journal:  Food Sci Biotechnol       Date:  2018-01-12       Impact factor: 2.391

4.  Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands.

Authors:  Stephanie N Lewis; Zulma Garcia; Raquel Hontecillas; Josep Bassaganya-Riera; David R Bevan
Journal:  J Comput Aided Mol Des       Date:  2015-01-24       Impact factor: 3.686

Review 5.  Reviewing ligand-based rational drug design: the search for an ATP synthase inhibitor.

Authors:  Chia-Hsien Lee; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Int J Mol Sci       Date:  2011-08-17       Impact factor: 5.923

6.  Boehmeria nivea Stimulates Glucose Uptake by Activating Peroxisome Proliferator-Activated Receptor Gamma in C2C12 Cells and Improves Glucose Intolerance in Mice Fed a High-Fat Diet.

Authors:  Sung Hee Kim; Mi Jeong Sung; Jae Ho Park; Hye Jeong Yang; Jin-Taek Hwang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-03       Impact factor: 2.629

7.  Identification of PPARgamma partial agonists of natural origin (I): development of a virtual screening procedure and in vitro validation.

Authors:  Laura Guasch; Esther Sala; Anna Castell-Auví; Lidia Cedó; Klaus R Liedl; Gerhard Wolber; Markus Muehlbacher; Miquel Mulero; Montserrat Pinent; Anna Ardévol; Cristina Valls; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Identification of PPARgamma partial agonists of natural origin (II): in silico prediction in natural extracts with known antidiabetic activity.

Authors:  Laura Guasch; Esther Sala; Miquel Mulero; Cristina Valls; Maria Josepa Salvadó; Gerard Pujadas; Santiago Garcia-Vallvé
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

Review 9.  Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review.

Authors:  Limei Wang; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Martina Blunder; Xin Liu; Clemens Malainer; Tina Blazevic; Stefan Schwaiger; Judith M Rollinger; Elke H Heiss; Daniela Schuster; Brigitte Kopp; Rudolf Bauer; Hermann Stuppner; Verena M Dirsch; Atanas G Atanasov
Journal:  Biochem Pharmacol       Date:  2014-07-30       Impact factor: 5.858

Review 10.  Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones.

Authors:  D Alemán-González-Duhart; F Tamay-Cach; S Álvarez-Almazán; J E Mendieta-Wejebe
Journal:  PPAR Res       Date:  2016-05-23       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.